Showing results (1071-1080 of 1,155) with videos related to

Sort By:
Pageof 116
Journal of the National Comprehensive Cancer Network : JNCCN|October 22, 2013
Ovarian cancer, version 2.2013Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Annals of Surgical Oncology|February 8, 2023
Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II TrialC Bakkers, K P Rovers, A Rijken, et al.
AIDS (London, England)|September 13, 2023
Virological and immunological correlates of HIV posttreatment control after temporal antiretroviral therapy during acute HIV infectionPien M van Paassen, Lisa van Pul, Karlijn van der Straten, et al.
JAMA Oncology|June 10, 2021
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 TrialNitin Jain, Michael Keating, Philip Thompson, et al.
Cancer|March 19, 2021
Long-term follow-up of salvage therapy using a combination of inotuzumab ozogamicin and mini-hyper-CVD with or without blinatumomab in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemiaElias Jabbour, Koji Sasaki, Nicholas J Short, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2025
Treatment and outcomes of local re-recurrence in rectal cancer: a multicentre observational cohortD M J Creemers, D M Mens, S Nordkamp, et al.
BMJ Open|January 18, 2024
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trialVincent C J van de Vlasakker, Niels A D Guchelaar, Teun B M van den Heuvel, et al.
Iscience|October 16, 2023
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individualDenise Guerra, Tim Beaumont, Laura Radić, et al.
Evolutionary Applications|December 16, 2024
Dealing With the Complexity of Effective Population Size in Conservation PracticeAncuta Fedorca, Joachim Mergeay, Adejoke O Akinyele, et al.
Pageof 116